메뉴 건너뛰기




Volumn 21, Issue 10, 2015, Pages 899-905

Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin

Author keywords

Colistin; Fosfomycin; Mecillinam; Nitrofurantoin; Temocillin

Indexed keywords

COLISTIN; FOSFOMYCIN; MECILLINAM; NITROFURANTOIN; TEMOCILLIN; ANTIINFECTIVE AGENT;

EID: 84942199836     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.022     Document Type: Review
Times cited : (114)

References (47)
  • 2
    • 77957951965 scopus 로고    scopus 로고
    • Resistance to polymyxins: mechanisms, frequency and treatment options
    • Falagas M.E., Rafailidis P.I., Matthaiou D.K. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 2010, 13:132-138.
    • (2010) Drug Resist Updat , vol.13 , pp. 132-138
    • Falagas, M.E.1    Rafailidis, P.I.2    Matthaiou, D.K.3
  • 3
    • 84926489004 scopus 로고    scopus 로고
    • The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
    • Poirel L., Jayol A., Bontron S., et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015, 70:75-80.
    • (2015) J Antimicrob Chemother , vol.70 , pp. 75-80
    • Poirel, L.1    Jayol, A.2    Bontron, S.3
  • 4
    • 84905399119 scopus 로고    scopus 로고
    • Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin
    • Jayol A., Poirel L., Brink A., Villegas M.V., Yilmaz M., Nordmann P. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 2014, 58:4762-4766.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 4762-4766
    • Jayol, A.1    Poirel, L.2    Brink, A.3    Villegas, M.V.4    Yilmaz, M.5    Nordmann, P.6
  • 5
    • 84885909781 scopus 로고    scopus 로고
    • In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator
    • Cannatelli A., D'Andrea M.M., Giani T., et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 2013, 57:5521-5526.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 5521-5526
    • Cannatelli, A.1    D'Andrea, M.M.2    Giani, T.3
  • 6
    • 84905394181 scopus 로고    scopus 로고
    • In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment
    • Cannatelli A., Di Pilato V., Giani T., et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob Agents Chemother 2014, 58:4399-4403.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 4399-4403
    • Cannatelli, A.1    Di Pilato, V.2    Giani, T.3
  • 7
    • 84921029928 scopus 로고    scopus 로고
    • Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
    • Sader H.S., Farrell D.J., Castanheira M., Flamm R.K., Jones R.N. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12). J Antimicrob Chemother 2014, 69:2713-2722.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 2713-2722
    • Sader, H.S.1    Farrell, D.J.2    Castanheira, M.3    Flamm, R.K.4    Jones, R.N.5
  • 9
    • 84878469949 scopus 로고    scopus 로고
    • Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011
    • Giani T., Pini B., Arena F., et al. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 2013, 18:20489.
    • (2013) Euro Surveill , vol.18 , pp. 20489
    • Giani, T.1    Pini, B.2    Arena, F.3
  • 10
    • 84899545436 scopus 로고    scopus 로고
    • Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates
    • Pena I., Picazo J.J., Rodríguez-Avial C., Rodríguez-Avial I. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents 2014, 43:460-464.
    • (2014) Int J Antimicrob Agents , vol.43 , pp. 460-464
    • Pena, I.1    Picazo, J.J.2    Rodríguez-Avial, C.3    Rodríguez-Avial, I.4
  • 11
    • 0021189968 scopus 로고
    • Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins
    • Labia R., Baron P., Masson J.M., Hill G., Cole M. Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins. Antimicrob Agents Chemother 1984, 26:335-338.
    • (1984) Antimicrob Agents Chemother , vol.26 , pp. 335-338
    • Labia, R.1    Baron, P.2    Masson, J.M.3    Hill, G.4    Cole, M.5
  • 13
    • 38449088541 scopus 로고    scopus 로고
    • Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection
    • De Jongh R., Hens R., Basma V., Mouton J.W., Tulkens P.M., Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008, 61:382-388.
    • (2008) J Antimicrob Chemother , vol.61 , pp. 382-388
    • De Jongh, R.1    Hens, R.2    Basma, V.3    Mouton, J.W.4    Tulkens, P.M.5    Carryn, S.6
  • 15
    • 35348819978 scopus 로고    scopus 로고
    • In vitro activity of temocillin against prevalent extended-spectrum β-lactamases producing Enterobacteriaceae from Belgian intensive care units
    • Glupczynski Y., Huang T.D., Berhin C., et al. In vitro activity of temocillin against prevalent extended-spectrum β-lactamases producing Enterobacteriaceae from Belgian intensive care units. Eur J Clin Microbiol Infect Dis 2007, 26:777-783.
    • (2007) Eur J Clin Microbiol Infect Dis , vol.26 , pp. 777-783
    • Glupczynski, Y.1    Huang, T.D.2    Berhin, C.3
  • 16
    • 33645836294 scopus 로고    scopus 로고
    • Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England
    • Livermore D.M., Hope R., Fagan E.J., Warner M., Woodford N., Potz N. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England. J Antimicrob Chemother 2006, 57:1012-1014.
    • (2006) J Antimicrob Chemother , vol.57 , pp. 1012-1014
    • Livermore, D.M.1    Hope, R.2    Fagan, E.J.3    Warner, M.4    Woodford, N.5    Potz, N.6
  • 17
    • 84910023053 scopus 로고    scopus 로고
    • Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea
    • Seo M.R., Kim S.J., Kim Y., et al. Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. J Korean Med Sci 2014, 29:1178-1181.
    • (2014) J Korean Med Sci , vol.29 , pp. 1178-1181
    • Seo, M.R.1    Kim, S.J.2    Kim, Y.3
  • 18
    • 81355149261 scopus 로고    scopus 로고
    • Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
    • Titelman E., Iversen A., Kahlmeter G., Giske C.G. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae. APMIS 2011, 119:853-863.
    • (2011) APMIS , vol.119 , pp. 853-863
    • Titelman, E.1    Iversen, A.2    Kahlmeter, G.3    Giske, C.G.4
  • 20
    • 84892471881 scopus 로고    scopus 로고
    • In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase
    • Woodford N., Pike R., Meunier D., Loy R., Hill R., Hopkins K.L. In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. J Antimicrob Chemother 2014, 69:564-567.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 564-567
    • Woodford, N.1    Pike, R.2    Meunier, D.3    Loy, R.4    Hill, R.5    Hopkins, K.L.6
  • 21
    • 84892470726 scopus 로고    scopus 로고
    • Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers
    • Huang T.D., Poirel L., Bogaerts P., Berhin C., Nordmann P., Glupczynski Y. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother 2014, 69:445-450.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 445-450
    • Huang, T.D.1    Poirel, L.2    Bogaerts, P.3    Berhin, C.4    Nordmann, P.5    Glupczynski, Y.6
  • 22
    • 84902209071 scopus 로고    scopus 로고
    • Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance
    • Castañeda-García A., Blázquez J., Rodríguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics 2013, 2:217-236.
    • (2013) Antibiotics , vol.2 , pp. 217-236
    • Castañeda-García, A.1    Blázquez, J.2    Rodríguez-Rojas, A.3
  • 23
    • 84929574307 scopus 로고    scopus 로고
    • Working Party 'Antimicrobial Resistance' of the Paul-Ehrlich-Society for Chemotherapy. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin
    • Kresken M., Pfeifer Y., Hafner D., Wresch R., Körber-Irrgang B. Working Party 'Antimicrobial Resistance' of the Paul-Ehrlich-Society for Chemotherapy. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin. Int J Antimicrob Agents 2014, 44:295-300.
    • (2014) Int J Antimicrob Agents , vol.44 , pp. 295-300
    • Kresken, M.1    Pfeifer, Y.2    Hafner, D.3    Wresch, R.4    Körber-Irrgang, B.5
  • 24
    • 84901649592 scopus 로고    scopus 로고
    • Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany
    • Kaase M., Szabados F., Anders A., Gatermann S.G. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol 2014, 52:1893-1897.
    • (2014) J Clin Microbiol , vol.52 , pp. 1893-1897
    • Kaase, M.1    Szabados, F.2    Anders, A.3    Gatermann, S.G.4
  • 25
    • 84893169017 scopus 로고    scopus 로고
    • In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012)
    • Lai B., Zheng B., Li Y., Zhu S., Tong Z. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012). BMC Infect Dis 2014, 14:66.
    • (2014) BMC Infect Dis , vol.14 , pp. 66
    • Lai, B.1    Zheng, B.2    Li, Y.3    Zhu, S.4    Tong, Z.5
  • 26
    • 84908152273 scopus 로고    scopus 로고
    • Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study
    • Sorlozano A., Jimenez-Pacheco A., de Dios Luna Del Castillo J., et al. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study. Am J Infect Control 2014, 42:1033-1038.
    • (2014) Am J Infect Control , vol.42 , pp. 1033-1038
    • Sorlozano, A.1    Jimenez-Pacheco, A.2    de Dios Luna Del Castillo, J.3
  • 27
    • 84906078362 scopus 로고    scopus 로고
    • Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals
    • Chan J., Lo W.U., Chow K.H., Lai E.L., Law P.Y., Ho P.L. Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals. Antimicrob Agents Chemother 2014, 58:5638-5639.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 5638-5639
    • Chan, J.1    Lo, W.U.2    Chow, K.H.3    Lai, E.L.4    Law, P.Y.5    Ho, P.L.6
  • 28
    • 0033833440 scopus 로고    scopus 로고
    • Pivmecillinam in the treatment of urinary tract infections
    • Nicolle L.E. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 2000, 46(Suppl. 1):35-39.
    • (2000) J Antimicrob Chemother , vol.46 , pp. 35-39
    • Nicolle, L.E.1
  • 29
    • 1642422921 scopus 로고    scopus 로고
    • Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole
    • Kerrn M.B., Frimodt-Møller N., Espersen F. Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole. Clin Microbiol Infect 2004, 10:54-61.
    • (2004) Clin Microbiol Infect , vol.10 , pp. 54-61
    • Kerrn, M.B.1    Frimodt-Møller, N.2    Espersen, F.3
  • 30
    • 0035468838 scopus 로고    scopus 로고
    • Effect of antimicrobial agents on the ecological balance of human microflora
    • Sullivan Å., Edlund C., Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001, 1:101-114.
    • (2001) Lancet Infect Dis , vol.1 , pp. 101-114
    • Sullivan, Å.1    Edlund, C.2    Nord, C.E.3
  • 31
    • 0017683098 scopus 로고
    • The mechanism of action of mecillinam
    • Spratt B.G. The mechanism of action of mecillinam. J Antimicrob Chemother 1977, 3:13-19.
    • (1977) J Antimicrob Chemother , vol.3 , pp. 13-19
    • Spratt, B.G.1
  • 32
    • 0013096299 scopus 로고
    • Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12
    • Spratt B.G. Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proc Natl Acad Sci U S A 1975, 72:2999-3003.
    • (1975) Proc Natl Acad Sci U S A , vol.72 , pp. 2999-3003
    • Spratt, B.G.1
  • 33
    • 84894088675 scopus 로고    scopus 로고
    • Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections
    • Jansåker F., Frimodt-Møller N., Sjögren I., Dahl Knudsen J. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. J Antimicrob Chemother 2014, 69:769-772.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 769-772
    • Jansåker, F.1    Frimodt-Møller, N.2    Sjögren, I.3    Dahl Knudsen, J.4
  • 34
    • 84859619515 scopus 로고    scopus 로고
    • Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    • Titelman E., Iversen A., Kalin M., Giske C.G. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 2012, 18:189-192.
    • (2012) Microb Drug Resist , vol.18 , pp. 189-192
    • Titelman, E.1    Iversen, A.2    Kalin, M.3    Giske, C.G.4
  • 35
    • 84898629855 scopus 로고    scopus 로고
    • High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli
    • Søraas A., Sundsfjord A., Jørgensen S.B., Liestøl K., Jenum P.A. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. PLoS One 2014, 9:e85889.
    • (2014) PLoS One , vol.9 , pp. e85889
    • Søraas, A.1    Sundsfjord, A.2    Jørgensen, S.B.3    Liestøl, K.4    Jenum, P.A.5
  • 36
    • 0033824888 scopus 로고    scopus 로고
    • Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases
    • Sougakoff W., Jarlier V. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. J Antimicrob Chemother 2000, 46(Suppl. A):9-14.
    • (2000) J Antimicrob Chemother , vol.46 , pp. 9-14
    • Sougakoff, W.1    Jarlier, V.2
  • 37
    • 84937694499 scopus 로고    scopus 로고
    • In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase
    • Marrs E.C., Day K.M., Perry J.D. In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase. J Antimicrob Chemother 2014, 69:2873-2875.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 2873-2875
    • Marrs, E.C.1    Day, K.M.2    Perry, J.D.3
  • 38
    • 84923250957 scopus 로고    scopus 로고
    • Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli
    • Thulin E., Sundqvist M., Andersson D.I. Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. Antimicrob Agents Chemother 2015, 59:1718-1727.
    • (2015) Antimicrob Agents Chemother , vol.59 , pp. 1718-1727
    • Thulin, E.1    Sundqvist, M.2    Andersson, D.I.3
  • 39
    • 0141758347 scopus 로고    scopus 로고
    • Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study
    • Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study. Int J Antimicrob Agents 2003, 22(Suppl. 2):49-52.
    • (2003) Int J Antimicrob Agents , vol.22 , pp. 49-52
    • Kahlmeter, G.1
  • 40
    • 82955187565 scopus 로고    scopus 로고
    • Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO-SENS study revisited
    • Kahlmeter G., Poulsen H.O. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO-SENS study revisited. Int J Antimicrob Agents 2012, 39:45-51.
    • (2012) Int J Antimicrob Agents , vol.39 , pp. 45-51
    • Kahlmeter, G.1    Poulsen, H.O.2
  • 42
    • 77950353740 scopus 로고    scopus 로고
    • Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins
    • Wootton M., Walsh T.R., Macfarlane L., Howe R.A. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2010, 65:79-81.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 79-81
    • Wootton, M.1    Walsh, T.R.2    Macfarlane, L.3    Howe, R.A.4
  • 44
    • 0017833324 scopus 로고
    • The pharmacokinetics of nitrofurantoin and its related bioavailability
    • Conklin J.D. The pharmacokinetics of nitrofurantoin and its related bioavailability. Antibiot Chemother 1978, 25:233-252.
    • (1978) Antibiot Chemother , vol.25 , pp. 233-252
    • Conklin, J.D.1
  • 45
    • 84936932880 scopus 로고    scopus 로고
    • Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota
    • In press
    • Vervoort J., Xavier B.B., Stewardson A., et al. Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota. J Antimicrob Chemother 2015, In press.
    • (2015) J Antimicrob Chemother
    • Vervoort, J.1    Xavier, B.B.2    Stewardson, A.3
  • 46
    • 84912533203 scopus 로고    scopus 로고
    • An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli
    • Vervoort J., Xavier B.B., Stewardson A., et al. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 2014, 58:7225-7233.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 7225-7233
    • Vervoort, J.1    Xavier, B.B.2    Stewardson, A.3
  • 47
    • 0028285474 scopus 로고
    • Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens
    • McOsker C.C., Fitzpatrick P.M. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994, 33(Suppl. A):23-30.
    • (1994) J Antimicrob Chemother , vol.33 , pp. 23-30
    • McOsker, C.C.1    Fitzpatrick, P.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.